McDermott advised Pierre Fabre in this transaction. The French pharmaceutical and dermo-cosmetic company, Pierre Fabre, has recently entered into an exclusive collaboration and licensing agreement with...
Pierre Fabre’s Signature of a Collaboration and Licensing Agreement with Scorpion Therapeutics
Pierre Fabre’s Outsourcing of its Digital Transformation and Cybersecurity
IN BRIEF: Astura, Walter Billet, advised on the matter. Astura advised Fujitsu with a team including Matthieu M?in (Commercial Law). Walter Billet advised Pierre Fabre S.A....
Atara Biotherapeutics’ Strategic Agreement with Pierre Fabre
McDermott Will & Emery advised Pierre Fabre on the deal. Pierre Fabre finalized a strategic collaboration with Atara Biotherapeutics to commercialize Tab-cel® in Europe, the Middle East,...
Pierre Fabre’s Licence Agreement with ValenzaBio
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised Pierre Fabre S.A. with a team including Emmanuelle Trombe (Picture –...
Puma Biotechnology and Pierre Fabre’s Amendment of NERLYNX License Agreement
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised Pierre Fabre S.A. with a team including Anne-France Moreau (Life Science...